Skip to main content
SpringerLink
Log in

Driving sustainability through adoption of hybrid manufacturing in small molecule API production

  • Perspectives
  • Published:
Journal of Flow Chemistry Aims and scope Submit manuscript

Abstract

Pharmaceutical industry is challenged by the rising development costs, strict regulatory and environmental requirements all while racing to deliver complex molecules to market. The need to be the first-in-class brings about shorter lifetime to the launched products in favor of better functioning followers. In addition, a shift from large volume blockbusters towards small volume production of complex molecules presents a unique opportunity to challenge the status quo in pharmaceutical manufacturing. Traditional batch manufacturing, while foundational, presents hurdles in scaling and efficiency, particularly for demanding reactions. Continuous manufacturing has emerged as a promising alternative, delivering better control and uniformity of operating conditions, mirroring the efficiencies found in small-scale batch reactors. However, continuous manufacturing is not universally applicable. As a solution, a combination of the two into hybrid manufacturing processes, appears to fill this gap effectively. While the concept of hybrid manufacturing is not new, the current perspective adds an additional angle to the integration of both technologies. Authors propose to sustain the continuity of the operation for batch mode processes by decreasing the reactor size and increasing the level of automation. Furthermore, modular fabrication of smaller-footprint technological platforms is expected to synergize other advancements in the field, such as digitalization, automation, and standardization. As a result, a leap towards the implementation of advanced manufacturing to drive sustainability in pharmaceutical industry is more tangible than ever.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Deloitte (2023) Seize the digital momentum. Measuring the return from pharmaceutical innovation, https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/deloitte-ch-en-lshc-seize-digital-momentum-rd-roi-2022.pdf Accessed 13 February 2024

  2. Buntz B (2023) Small molecule trends to follow in 2023, https://www.drugdiscoverytrends.com/small-molecule-trends-to-follow-in-2023/ Accessed 13 February 2024

  3. Spring L, Demuren K, Ringel M, Wu J (2023) First-in-class versus best-in-class: an update for new market dynamics. Nat Rev Drug Discovery 22:531–532

    Article  CAS  PubMed  Google Scholar 

  4. Caygill G, Zanfir M, Gavriilidis A (2006) Scalable Reactor Design for pharmaceuticals and Fine Chemicals Production. 1: potential scale-up obstacles. OPRD 10(3):539–552

    Article  CAS  Google Scholar 

  5. Jimenez-Gonzalez C, Ponder CS, Broxterman QB, Manley JB (2011) OPRD 15(4):912–917

    Article  CAS  Google Scholar 

  6. Cole KP, Johnson MD (2018) Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds. Expert Rev Clin Pharmacol 11(1):5–13

    Article  CAS  PubMed  Google Scholar 

  7. Baumann M, Moody TS, Smyth M, Wharry S A Perspective on Continuous Flow Chemistry in the Pharmaceutical Industry. OPRD 24 (10): 1802–1813 b), Borukhova S, Noël T, Metten B, de Vos E, Hessel V (2020) (2013) Solvent- and Catalyst-Free Huisgen Cycloaddition to Rufinamide in Flow with a Greener, Less Expensive Dipolarophile. ChemSusChem 6: 2220–2225

  8. Ehrfeld W, Hessel V, Löwe H (2000) Microreactors: New Technology for Modern Chemistry, Wiley–VCH, Weinheim, Germany ISBN 3-527-29590-9

  9. Wright R Pfizer’s Hybrid Approach To Implementing Continuous Manufacturing Processes. Life Science Leader https://, Domokos A, Nagy B, Szilágyi B, Marosi G, Nagy ZK (2013) (2021) Integrated Continuous Pharmaceutical Technologies—A Review. OPRD 25 (4): 721–739

  10. Doyle BJ, Elsner P, Gutmann B, Hannaerts O, Aellig C, Macchi A, Roberge DM (2020) Mini-monoplant Technology for Pharmaceutical Manufacturing. OPRD 24(10):2169–2182

  11. Hroncich C (2016) New directions in Modular Manufacturing. Pharm Technol 40 (9)

  12. Singh AK A Bottom-Up Approach to Process Development: Application of Physicochemical Properties of Reaction Products toward the Development of Direct-Drop Processes OPRD 5 (5): 508–513 b), Cornwall P, Diorazio LJ, Monks N (2001) (2018) Route design, the foundation of successful chemical development. Bioorganic & Medicinal Chemistry, 26(14): 4336–4347

  13. Martin B, Lehmann H, Yang H, Chen L, Tian X, Polenk J, Schenkel B (2018) Continuous manufacturing as an enabling tool with green credentials in early-phase pharmaceutical chemistry. Curr Opin Green Sustainable Chem 11:27–33

    Article  Google Scholar 

  14. Lee SL, O’Connor TF, Yang X (2015) Modernizing Pharmaceutical Manufacturing: from batch to continuous production. J Pharm Innov 10:191–199

    Article  Google Scholar 

  15. Lee SL (2016) Current FDA Perspective for Continuous Manufacturing, MIT-CMAC 2nd International Symposium on Continuous Manufacturing of Pharmaceuticals September 26–27

  16. Anderson NG (2012) Practical Process Research and Development: A guide for Organic Chemists, Chap. 8, 209–235 ISBN 978-0-12-386537-3

  17. Wang K, Teixeira AR, Jensen KF, Luo G Design and Scaling Up of Microchemical Systems: A Review. Annual Review of Chemical and Biomolecular Engineering 8(1): 285–305 b), Dong Z, Wen Z, Zhao F, Kuhn S, Noël T (2017) (2021) Scale-up of micro- and milli-reactors: An overview of strategies, design principles and applications. Chem Eng Sci, 10: 100097

  18. Roberge DM An Integrated Approach Combining Reaction Engineering and Design of Experiments for Optimizing Reactions Dominique OPRD 8 (6): 1049–1053 b), Taylor CJ, Pomberger A, Felton KC, Grainger R, Barecka M, Chamberlain TW, Bourne RA, Johnson CN, Lapkin AA (2004) (2023) A Brief Introduction to Chemical Reaction Optimization. Chemical Reviews 123 (6): 3089–3126

  19. Kockmann N (2016) Modular equipment for chemical process development and small-scale production in multipurpose plants ChemBioEng. Reviews 3(1):5–15

    Google Scholar 

  20. Baldea M, Edgar TF, Stanley BL, Kiss AA Modular manufacturing processes: Status, challenges, and opportunities. AI Ch E Journal, 63(10): 4262–4272. b), Kapoor Y, Meyer RF (2017) MeyerBK (2021) Flexible Manufacturing: The Future State of Drug Product Development and Commercialization in the Pharmaceutical Industry. J Pharm Innov 16: 2–10

  21. Becker T, Lier S, Werners B (2019) Value of modular production concepts in future chemical industry production networks. Eur J Oper Res 276(3):957–970

    Article  Google Scholar 

  22. Moulijn JA Process Intensification: Transforming Chemical Engineering. Chem. Eng. Prog. 96(1):22– 34 b) Reay D A, Ramshaw C, Harvey A (2013) Process Intensification: Engineering for Efficiency, Sustainability and Flexibility, 2ndButterworth-Heinemann: Oxford, U.K (c) Ramshaw C (1995) The Incentive for Process Intensification. BHR Group Conf. Ser. 18: 1– 4 d), Moulijn A, Stankiewicz JG, Górak A (2000) (2008) Comput. Chem. Eng., 32: 3

  23. Noël T, Metten B, de Vos E, Hessel V From alcohol to 1,2,3-triazole via a multi-step continuous-flow synthesis of a rufinamide precursor Green Chem 18: 4947–4953 b), Hessel V, Kralisch D, Kockmann N (2014) Novel process windows: innovative gates to intensified and sustainable chemical processes. John Wiley, Sons N, Roberge DM. (2009) Harsh reaction conditions in continuous flow microreactors for pharmaceutical production. Chem Eng Technol 32(11):1682–1694 d), Gutmann B, Kappe CO (2016) (2017) Forbidden chemistries — paths to a sustainable future engaging continuous processing. Journal of Flow Chemistry 7(3–4): 65–71

  24. Sonley M, Wingate G Implementing S88 Batch Control Systems in the Pharmaceutical Industry. Measurement and Control. 31(1):20–24. b), Markarian J (1998) (2018) Modernizing Pharma Manufacturing. Pharmaceutical Technology 42 (4):20–25

  25. Merkelbach S, Menschner A, Hensel S, Heinze S, Bittorf L, Kockmann N, Schäfer C, Szmais S, Eckert M Orchestration Requirements for Modular Process Plants in Chemical and Pharmaceutical Industries. Chem. Eng. Technol. 42: 2282–2291. b), Wetterich P, Kuhr MMG, Pelz PF (2023) Model-Based Condition Monitoring of Modular Process Plants, Processes, 11 (9)2733 c) Yingjie C, Yang O, Sampat C, Bhalode P, Ramachandran R, Ierapetritou M (2019) (2020) Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review. Processes 8(9): 1088

  26. Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J Understanding Pharmaceutical Quality by Design AAPS J 16: 771–783 b), Grangeia HB, Silva C, Simões SP, Reis MS (2014) (2020) Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives, European Journal of Pharmaceutics and Biopharmaceutics 147: 19–37

Download references

Acknowledgements

We would like to thank David Maltete, Andrew Rutter, Adria La Porta, Flavien Susanne, Jason Tedrow and Matthieu Cortinovis for their unyielding support in the endeavor of continuous manufacturing implementation.

Author information

Authors and Affiliations

  1. Manufacturing Sciences and Analytical Technologies, Sanofi Chimie, 30390, Route d’Avignon, Aramon, France

    Svetlana Borukhova & Robert Sebastian Rönnback

Authors
  1. Svetlana Borukhova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Sebastian Rönnback
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Svetlana Borukhova.

Ethics declarations

Conflict of interest

Authors certify that there is no actual or potential conflict of interest in relation to this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Borukhova, S., Rönnback, R. Driving sustainability through adoption of hybrid manufacturing in small molecule API production. J Flow Chem 14, 303–312 (2024). https://doi.org/10.1007/s41981-024-00325-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41981-024-00325-0

Keywords

Search

Navigation